Assessment of the Potential Interactions Between Cocaine and GBR 12909 - 1

Phase 1

• Conditions: Cocaine-Related Disorders

• Registration Number: NCT00051896
• Lead Sponsor: National Institute on Drug Abuse (NIDA)

Brief Summary

The purpose of this study is to assess the potential interactions between iv cocaine and GBR 12909.

Detailed Description

This is a single dose with escalation, double-blind, placebo-controlled inpatient study in which 24 cocaine experienced volunteers that meet protocol eligibility criteria during a 30 day screen period will be randomized into three dose groups.

Study Timeline

• Study Start: 2002-08
• Study First Submitted: 2003-01-17
• Study First Submitted QC: 2003-01-17
• Study First Posted: 2003-01-20
• Status Verified: 2005-03
• Last Update Submitted: 2017-01-10
• Last Update Posted: 2017-01-11

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

• Must understand study procedures and provide written informed consent
• For additional inclusion criteria information, please contact study site for more information.

Exclusion Criteria

• Please contact study site for more information.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pharmacokinetic parameter comparison

Trial Locations

Locations (1)

Uniformed Services University of Health Science; 🇺🇸 Bethesda, Maryland, United States